
Loading, please wait...

Loading, please wait...

Clinical decisions in neurosurgery are increasingly supported by epilepsy surgery prediction models. A systematic review recently assessed 113 of these models across 42 papers to evaluate their clinical utility. Researchers found that these tools typically achieve a median area under the curve (AUC) of 0.75 and a median accuracy of 0.76. Consequently, these results indicate that current models provide a reasonable baseline for forecasting postoperative success and informing patient counseling.
Despite the high number of available tools, significant methodological gaps persist in the literature. For example, only 54% of the analyzed models underwent internal validation. More concerningly, just 20.4% of these models received rigorous external validation. Researchers also categorized the risk of bias as high in 81% of the evaluated models. These biases primarily stem from weaknesses in statistical analysis and inconsistent outcome definitions. Therefore, clinicians should exercise caution when implementing these epilepsy surgery prediction models in routine practice without further validation.
Fortunately, the quality of evidence in this field is trending toward improvement over time. Newer publications demonstrate better adherence to standardized reporting guidelines, which enhances the reliability of the findings. Moreover, models focusing on cognitive-language outcomes generally performed better than those predicting general seizure freedom. If researchers continue to prioritize external validation and minimize bias, these predictive tools will eventually become indispensable assets for personalized epilepsy management and surgical planning.
The median accuracy for most evaluated models is approximately 0.76. While this shows promise, the high risk of bias in many studies suggests that these figures may be optimistic and require further verification.
External validation tests a model on a completely new patient population. Without it, a model might only work well for the specific group it was developed for, which limits its usefulness in different clinical settings or hospitals.
Evidence suggests that models designed to predict cognitive and language outcomes often perform better than models focused on other surgical metrics, such as general seizure-free status.
Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Federico AA et al. Can we predict surgical outcomes: A systematic review and critical appraisal of clinical prediction models in epilepsy surgery. Epilepsia. 2026 May 05. doi: 10.1002/epi.70274. PMID: 42084861.
Moons KGM et al. PROBAST: A Tool to Assess the Risk of Bias and Applicability of Prediction Model Studies. Ann Intern Med. 2019;170(1):W1-W33.
Collins GS et al. Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): the TRIPOD statement. BMJ. 2015;350:g7594.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A systematic review of 113 epilepsy surgery prediction models reveals moderate accuracy but highlights a high risk of bias and lack of external validation....
4 months ago

Explore the emerging role of Brixadi, an extended-release buprenorphine injection, for managing stimulant use disorder through kappa opioid receptor antagonism and steady plasma levels.
Today

A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today

Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today

Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday

Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today